| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
5.2e-05 |
1 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-12 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
3e-11 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
3e-11 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
6e-11 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
7e-11 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
7e-11 |